New data presented by ABL Medical demonstrate that fiber optic technology combined with blue light can be adapted for antimicrobial applications. Laboratory experiments have shown that specific frequencies of blue light have antimicrobial effects. However, different species of bacteria respond differently to these frequencies.
Blue light acts on pathogens by stimulating their oxygen-carrying molecules. These molecules begin to produce excessive amounts of unstable oxygen compounds (reactive oxygen species), which break down the basic building blocks of cells, including DNA bonds. The damage is so rapid and widespread that the microbes do not have the ability to defend themselves or develop resistance to the attack, as is the case with antibiotics.
ABL’s developing system utilizes a unique patented light source and optical delivery system with multiple light frequencies delivered through a single fiber optic. Unlike existing lighting systems that emit light from a single point (similar to flashlights), ABL’s multi-frequency system includes an optical fiber that can evenly emit blue light around a catheter or other medical instrument to achieve an antimicrobial process. This technology could enable the safe delivery of blue light to anatomical locations where this type of therapy could not be previously used.
The application of ABL’s fiber optic system emitting specific frequencies of antimicrobial blue light inside and around catheters has broad potential in medicine. Previous laboratory studies have been promising, and the ABL system has received numerous patents. The next step will involve conducting clinical trials to assess effectiveness and safety in various applications. Subsequently, the regulatory process will allow for commercial access to this innovative technology.
ABL’s technology is discussed at major scientific conferences, such as the European Congress of Clinical Microbiology and Infectious Diseases and the American Society for Microbiology Conference. Collaborating with ABL, IlluminOss Medical is a leader in innovative medical solutions.
However, it should be noted that ABL’s technology has not yet been approved by the Food and Drug Administration and is not currently available on the market. Nevertheless, its potential application in combating bacteria may open new possibilities in the field of medicine and hygiene.
FAQ: Fiber Optic Technology with Blue Light in Antimicrobial Applications
The source of the article is from the blog macholevante.com